GR Japan: FY2026 Drug Price Revision in Japan - Political Dynamics of Social Security Reform and an Overview of Institutional Design-
Drug pricing in Japan is no longer a technical exercise. It has become a frontline issue in social security reform and fiscal politics. Examining the FY2026 drug price revision through the interplay of political leadership, public–privat...